<DOC>
	<DOC>NCT01216943</DOC>
	<brief_summary>This study will investigate the safety and efficacy of Triple Combination Therapy (bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution) in patients with glaucoma or ocular hypertension who have elevated intraocular pressure (IOP) on brimonidine/timolol ophthalmic solution.</brief_summary>
	<brief_title>Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Glaucoma and/or ocular hypertension in both eyes Requires IOPlowering treatment in both eyes Other active ocular disease other than glaucoma or ocular hypertension (eg, uveitis, ocular infections or severe dry eye) Current or anticipated use of ocular medications other than study medications, except for intermittent use of artificial tears Use of oral, injectable or topical corticosteroids within 21 days Iridectomy or laser peripheral iridotomy in the study eye within 3 months Uncomplicated cataract surgery in the study eye within 6 months Incisional glaucoma surgery in the study eye within 12 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>